Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07590375
PHASE2/PHASE3

Topical Phenytoin for Management of Gingival Recession

Sponsor: Cairo University

View on ClinicalTrials.gov

Summary

Gingival recession (GR) is a term that describes the displacement of the gingival margin apical to the cemento-enamel junction (CEJ) of a tooth. The gold standard of GR treatment is surgical coverage through coronally advanced flap with subepithelial connective tissue graft (CAF+SCTG) (3). But, the need for a non-invasive technique for managing GR has not been frequently addressed. Phenytoin (PHT), used as an anti-seizure medication, has an established side effect of causing drug-influenced gingival enlargement. Its stimulatory effects on soft tissue metabolism suggested PHT to be tested topically for its effectiveness in wound healing. However, none of the previous studies that investigated topical phenytoin has assessed gingival recession; except for a case series.

Official title: Topical Phenytoin for Management of Gingival Recession: a Randomized Placebo-controlled Trial

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2026-06-01

Completion Date

2027-10

Last Updated

2026-05-15

Healthy Volunteers

No

Interventions

DRUG

phenytoin cream

Phenytoin 1% paste

OTHER

Placebo

placebo paste